ConductScience.org, home

Paper4451633

Radiosensitization of C3H mouse mammary tumours by a 2-nitroimidazole drug.

Sheldon PW and 2 others. Br J Cancer, 1974. Cited by 70 papers, by iCite.

Cite this record

ConductScience Library. Radiosensitization of C3H mouse mammary tumours by a 2-nitroimidazole drug. Papers, record 4451633. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4451633

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Radiosensitization of C3H mouse mammary tumours by a 2-nitroimidazole drug.
PubMed
Journal
Br J Cancer
PubMed
Year
1974
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
70
iCite
Relative citation ratio, by iCite
2.53
iCite
Revised in PubMed
2019-05-15
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sheldon PWP W
2Foster JLJ L
3Fowler JFJ F

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NitroimidazolesMajor topic
Radiation-Sensitizing AgentsMajor topic
1-Propanol
Animals
Female
Hypoxia
Mammary Neoplasms, Experimental
Mice
Mice, Inbred C3H
Neoplasm Transplantation
Oxygen Consumption
Preventive Medicine
Propanols
Radiotherapy Dosage
Transplantation, Homologous

Source PubMed

Download CSV of topics

References11

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15424290Studies of the toxicity and radiosensitising activity of triacetoneamine-N-oxyl in mice.Br J Radiol1970https://conductscience.org/library/papers/5424290PubMed
24991868A comparison of the response of tumour and normal tissue in the mouse exposed to single doses of fast neutrons or electrons.Br J Radiol1970https://conductscience.org/library/papers/4991868PubMed
35058971Induction of lung tumors and malignant lymphomas in mice by metronidazole.J Natl Cancer Inst1972https://conductscience.org/library/papers/5058971PubMed
45046526Current aspects of radiobiology as applied to radiotherapy.Clin Radiol1972https://conductscience.org/library/papers/5046526PubMed
54507330Preferential sensitization of hypoxic cells to radiation in vivo.Nat New Biol1972https://conductscience.org/library/papers/4507330PubMed
64520099Carcinogenicity of 5-nitrofurans, 5-nitroimidazoles, 4-nitrobenzenes, and related compounds.J Natl Cancer Inst1973https://conductscience.org/library/papers/4520099PubMed
74130856[Selective alterations of Purkinje cells in the dog after oral administration of high doses of nitroimidazole derivatives (author's transl)].Verh Dtsch Ges Pathol1972https://conductscience.org/library/papers/4130856PubMed
84798767Effectiveness of nitrofuran derivatives in sensitizing hypoxic mammalian cells to x rays.Br J Radiol1973https://conductscience.org/library/papers/4798767PubMed
94830160Letter: "High-dose" metronidazole: a preliminary pharmacological study prior to its investigational use in clinical radiotherapy trials.Br J Radiol1974https://conductscience.org/library/papers/4830160PubMed
104598448Chemical radiosensitization of hypoxic cells.Br Med Bull1973https://conductscience.org/library/papers/4598448PubMed
114608801Metronidazole ("Flagyl"). A radiosensitizer of hypoxic cells.Br J Radiol1974https://conductscience.org/library/papers/4608801PubMed

Download CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 70 citations.

PMIDTitleJournalYearIn PapersSource
37298933Design, Synthesis and Anticancer Evaluation of Nitroimidazole Radiosensitisers.Molecules2023https://conductscience.org/library/papers/37298933PubMed
22740186Synthesis and characterization of a hypoxia-sensitive MRI probe.Chemistry2012https://conductscience.org/library/papers/22740186PubMed
18544439New developments in radiation therapy for head and neck cancer: intensity-modulated radiation therapy and hypoxia targeting.Semin Oncol2008https://conductscience.org/library/papers/18544439PubMed
12610518A novel hypoxia-dependent 2-nitroimidazole KIN-841 inhibits tumour-specific angiogenesis by blocking production of angiogenic factors.Br J Cancer2003https://conductscience.org/library/papers/12610518PubMed
4008513Radiation therapy of rat brain tumor using misonidazole as hypoxic cell sensitizer.J Cancer Res Clin Oncol1985https://conductscience.org/library/papers/4008513PubMed
1156512Modest radiosensitization of solid tumours in C3H mice by the hypoxic cell radiosensitizer NDPP.Br J Cancer1975https://conductscience.org/library/papers/1156512PubMed
911657Further investigations of the effects of the hypoxic-cell radiosensitizer, Ro-07-0582, on local control of a mouse tumour.Br J Cancer1977https://conductscience.org/library/papers/911657PubMed
871368Cytotoxicity of Ro-07-0582; enhancement by hyperthermia and protection by cysteamine.Br J Cancer1977https://conductscience.org/library/papers/871368PubMed
871367Hypoxic cell radiosensitizers and local control by X-ray of a transplanted tumour in mice.Br J Cancer1977https://conductscience.org/library/papers/871367PubMed
869984Radiosensitizing and cytocidal effects on hypoxic cells of RO-07-0582, and repair of x-ray injury, in an experimental mouse tumour.Br J Cancer1977https://conductscience.org/library/papers/869984PubMed
708572Oncogenic transformation in vitro by the hypoxic cell sensitizer misonidazole.Br J Cancer1978https://conductscience.org/library/papers/708572PubMed
277241A comparison of the effects of tumour growth delay of fractionated and single dose irradiation when administered with misonidazole (Ro-07-0582).Br J Cancer Suppl1978https://conductscience.org/library/papers/277241PubMed
277239Radiosensitization by misonidazole (Ro-07-0582) of fractionated X-rays in a murine tumour.Br J Cancer Suppl1978https://conductscience.org/library/papers/277239PubMed
277222Enhancement of local tumour control by misonidazole and hyperthermia.Br J Cancer Suppl1978https://conductscience.org/library/papers/277222PubMed
75740Studies with bleomycin and misonidazole on aerated and hypoxic cells.Br J Cancer1978https://conductscience.org/library/papers/75740PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4451633

GET https://conductscience.org/api/papers/v1/4451633/authors